Karyopharm Therapeutics I... (KPTI)
NASDAQ: KPTI
· Real-Time Price · USD
5.96
1.31 (28.17%)
At close: Aug 15, 2025, 3:59 PM
5.60
-6.01%
After-hours: Aug 15, 2025, 07:58 PM EDT
Karyopharm Therapeutics Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -37.25M | -23.46M | -30.78M | -32.07M | 23.79M | -37.36M | -41.84M | -34.51M | -32.63M | -34.13M | -38.51M | -36.32M | -49.06M | -41.4M | 38.72M | -51.81M | -53.58M | -57.41M |
Depreciation & Amortization | -42K | 78K | 81K | -2.03M | 91K | 85K | 77K | 80K | 83K | 290K | 113K | 182K | 149K | 177K | 139K | 186K | 229K | 235K |
Stock-Based Compensation | 3.78M | 3.56M | 3.86M | 4.18M | 5.41M | 4.97M | 5.18M | 5.08M | 6.06M | 5.39M | 6.17M | 6.8M | 15.09M | 7.34M | 6.87M | 7.42M | 8.13M | 7.36M |
Other Working Capital | 11.24M | 2.22M | 9.14M | 2.47M | 377K | -8.77M | 5.59M | 6.97M | 5.3M | -8.1M | 4.06M | 6.69M | -1.58M | -25.13M | -17.92M | 14.76M | -9.03M | 2.93M |
Other Non-Cash Items | 4.76M | -17.64M | -8.38M | -13K | -58.32M | -703K | -8.67M | 205K | 190K | -921K | -532K | -87K | 198K | 241K | 199K | 7.55M | 113K | 273K |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | 7.87M | -936K | -1.01M | n/a | n/a | n/a | n/a | n/a | 571K | 114K | 119K | 650K |
Change in Working Capital | 10.05M | -1.52M | 9.41M | 10.48M | -9.47M | -10.71M | 18.79M | 549K | 1.61M | 10.46M | 5.91M | 1.06M | -1.41M | -25.55M | -21.02M | 12.59M | -10.76M | -3.99M |
Operating Cash Flow | -18.7M | -38.98M | -25.81M | -19.45M | -38.5M | -43.73M | -18.59M | -29.53M | -25.7M | -18.91M | -26.84M | -28.37M | -35.14M | -59.2M | 25.48M | -23.95M | -55.75M | -52.89M |
Capital Expenditures | n/a | n/a | 53K | n/a | n/a | -195K | n/a | n/a | n/a | n/a | 79K | -39K | n/a | -79K | -207K | -5K | n/a | n/a |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -11.71M | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | n/a | n/a | -1.51M | -20.8M | -4.9M | -31.61M | -16.56M | -46.06M | -36.19M | -60.33M | -97.1M | -29.9M | -63.48M | -35.54M | n/a | -10.5M | -8.97M | -25.76M |
Sales Maturities Of Investments | 18.29M | 15.29M | 16.25M | 28.28M | 56.16M | 53.74M | 43.4M | 38.38M | 57.36M | 27.94M | 31.8M | 41.61M | 26.88M | 21.58M | 30.48M | 37.93M | 55.43M | 68.95M |
Other Investing Acitivies | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 21.17M | n/a | -79K | 11.71M | -36.6M | -13.96M | 500K | -6M | 46.46M | 43.19M |
Investing Cash Flow | 18.29M | 15.29M | 14.8M | 7.47M | 51.26M | 21.94M | 26.84M | -7.68M | 21.17M | -32.39M | -65.3M | 11.67M | -36.6M | -14.04M | 30.77M | 21.43M | 46.46M | 43.19M |
Debt Repayment | n/a | n/a | 40.52M | n/a | 40.19M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | 111M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | n/a | n/a | -40.52M | n/a | n/a | n/a | n/a | 38.56M | 860K | n/a | 1.16M | 11K | 1.33M | 1.47M | 896K | 16K | 62.06M | 773K |
Financial Cash Flow | 356K | n/a | 680K | n/a | 40.97M | n/a | 264K | 38.56M | 860K | n/a | 155.84M | 5.8M | 1.31M | 30.78M | 896K | 16K | 62.06M | 10.68M |
Net Cash Flow | -48K | -23.69M | -10.35M | -11.94M | 53.72M | -21.8M | 8.61M | -37.27M | -3.69M | -51.34M | 63.83M | -10.97M | -70.88M | -42.54M | 57.01M | -2.27M | 52.71M | 883K |
Free Cash Flow | -18.7M | -38.98M | -25.76M | -19.45M | -38.5M | -43.92M | -18.59M | -29.53M | -25.7M | -18.91M | -26.76M | -28.41M | -35.14M | -59.28M | 25.27M | -23.96M | -55.75M | -52.89M |